Design and labeling differences between generic and reference listed drug inhalers: human factors considerations in US FDA-approved devices

Findings revealed that design and labeling differences can introduce cognitive and physical product use challenges, potentially impacting proper inhaler use and patient adherence. While this study relied solely on publicly available materials, future work should incorporate user testing, digital human modeling, and assessments across patient populations with varying use characteristics.